PPARG and cancer: We have evaluated the utility of both RAR and RXR specific ligands (rexinoids) as well as PPARγ ligands to decrease cancer cell proliferation, increase apoptosis and inhibit tumor growth with in vitro and in vivo experiments [6-8].